Othman Al-Sawaf is a haematologist and medical oncologist at the University Hospital Cologne, Cologne, Germany, and study physician at the German CLL Study Group (GCLLSG).
He studied medicine at the Medical School of RWTH Aachen University in Aachen, Germany, and joined the Department of Internal Medicine of Professor Michael Hallek at the University Hospital of Cologne in 2016. In 2020 he also joined the laboratory of Professor Charles Swanton at the Francis Crick Institute in London as a visiting scientist.
He works as coordinating physician and principal investigator for national and international phase I to III trials. In addition to his clinical trial work, he is interested in the principles of cancer evolution & metabolism. His research focusses on computational approaches for the discovery and development of new treatment strategies in clinical oncology.
EM-92415 - Date of preparation: March 2022